Dermatology · Cleveland, OH
NPI
1326067778
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
11100 Euclid Ave
Cleveland, OH, 44106
Phone (216) 844-8200
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
1,213 services
Medicare patients, 2024
264
Average age 74
Drug cost, 2024
$5.0M
1,717 prescriptions
Company payments, 2025
$91K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Neil J Korman was code 99213 (office e&m - established), 262 times for 170 patients. In total Neil J Korman billed 1,213 services in 31 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 262 | 170 | $59.32 | $16K |
| 17003 Destruction Skin Lesion | Office | 131 | 29 | $4.75 | $622 |
| 96900 Skin | Office | 120 | 16 | $16.71 | $2,005 |
| 99214 Office E&M - Established | Office | 108 | 74 | $87.12 | $9,409 |
| 17000 Destruction Skin Lesion | Office | 56 | 43 | $38.34 | $2,147 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 48 | 38 | $12.53 | $601 |
| 99203 Office E&M - New | Office | 30 | 30 | $75.47 | $2,264 |
| 11102 Skin Biopsy | Office | 27 | 21 | $58.97 | $1,592 |
| 99204 Office E&M - New | Office | 21 | 21 | $79.41 | $1,668 |
By year: 2022 $65K for 1,118 services; 2023 $54K for 1,011 services; 2024 $39K for 1,213 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88350 Immunohistochemistry | 144 | 32 | $86.82 | $13K |
| 88346 Immunohistochemistry | 35 | 29 | $107.43 | $3,760 |
Medicare prescription drug claims, 2024
In 2024, the drug Neil J Korman prescribed most often to Medicare patients was Prednisone, with 223 prescriptions and refills. In total Neil J Korman wrote 1,717 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 223 | 317 | 50 | $1,247 |
| Triamcinolone Acetonide Generic | 128 | 151 | 55 | $1,683 |
| Ketoconazole Generic | 126 | 155 | 43 | $2,814 |
| Mycophenolate Mofetil Generic | 105 | 191 | 33 | $23K |
| Azathioprine Generic | 66 | 141 | 17 | $4,293 |
| Clobetasol Propionate Generic | 65 | 69 | 33 | $5,066 |
| Humira(Cf) Pen Adalimumab | 63 | 63 | Under 11 | $561K |
| Skyrizi Pen Risankizumab-Rzaa | 59 | 154 | 20 | $1.2M |
| Dapsone Generic | 56 | 114 | 14 | $6,943 |
| Methotrexate Methotrexate Sodium | 56 | 109 | 16 | $789 |
| Tremfya Guselkumab | 55 | 101 | 13 | $741K |
| Hydroxyzine Hcl Generic | 44 | 59 | Under 11 | $276 |
| Dupixent Pen Dupilumab | 42 | 42 | Under 11 | $157K |
| Taltz Autoinjector Ixekizumab | 41 | 45 | Under 11 | $312K |
| Fluocinonide Generic | 40 | 40 | 15 | $1,666 |
Brand drugs: 544 claims; generic drugs: 1,173 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Neil J Korman $91K ($91K in general payments such as food, travel and fees) from 13 companies. The largest payer was Janssen Biotech, Inc. with $38K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 26 | $38K |
| UCB, Inc. UCB.BR | 26 | $22K |
| Abbvie Inc. ABBV | 11 | $14K |
| E.R. Squibb & Sons, L.L.C. BMY | 13 | $13K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 6 | $5,016 |
| Amgen Inc. AMGN | 1 | $22.11 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $18.33 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $18.04 |
| Galderma Laboratories, L.P. GALD.SW | 1 | $16.87 |
| Organon LLC OGN | 1 | $3.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.